Marion Morel

2PUBLICATIONS
2CO-AUTHORS
Solid tumoursPredictive and prognostic markers
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (2)

|Nov 20, 2023
FBXL16 promotes cell growth and drug resistance in lung adenocarcinomas with KRAS mutation by stabilizing IRS1 and upregulating IRS1/AKT signaling.

Marion Morel, Weiwen Long

|Apr 30, 2020
The F-box protein FBXL16 up-regulates the stability of C-MYC oncoprotein by antagonizing the activity of the F-box protein FBW7.

Marion Morel, Krushangi N Shah, Weiwen Long

Pageof 1

Frequent Collaborators

2 joint publications

Weiwen Long

1 joint publications

Krushangi N Shah